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Background: To explore the efficacy of cycle training in the treatment of intermittent claudication, the present study
compared performance and physiologic effects of cycle training with more conventional treadmill walking training in a
group of patients with claudication.
Method: Forty-two individuals with peripheral arterial disease and intermittent claudication (24 men, 18 women) were
stratified by gender and the presence or absence of type 2 diabetes mellitus and then randomized to a treadmill (n 13),
cycle (n 15), or control group (n 14). Treadmill and cycle groups trained three times a week for 6 weeks, whereas the
control group did not train during this period. Maximal and pain-free exercise times were measured on graded treadmill
and cycle tests before and after training.
Results: Treadmill training significantly improved maximal and pain-free treadmill walking times but did not improve
cycle performance. Cycle training significantly improved maximal cycle time but did not improve treadmill performance.
However, there was evidence of a stronger cross-transfer effect between the training modes for patients who reported a
common limiting symptom during cycling and walking at baseline. There was also considerable variation in the training
response to cycling, and a subgroup of responsive patients in the cycle group improved their walking performance bymore
than the average response observed in the treadmill group.
Conclusion: These findings suggest that cycle exercise is not effective in improving walking performance in all claudication
patients but might be an effective alternative to walking in those who exhibit similar limiting symptoms during both types
of exercise. ( J Vasc Surg 2006;44:119-27.)Improving exercise tolerance through supervised exer-
cise training is an important part of the medical treatment
of peripheral arterial disease (PAD) and intermittent clau-
dication.1 Walking has been the centerpiece of exercise
training programs for several decades,2,3 and it is seen to be
essential to maximizing the efficacy of training.4 However,
adherence to walking can be difficult for many patients with
claudication, as reflected in the relatively high drop-out
rates of about 30% from walking programs.5 Alternative
modes of exercise might thus be useful for patients and
treating clinicians alike. The effectiveness of other modes of
exercise such as cycling,6 resistance training,2,7 stairclimb-
ing,8 and arm-cranking6 has been studied to a very limited
extent. Of these alternative modes of exercise, cycling is
attractive to study because it is a relatively easy, inexpensive,
and safe exercise to perform and is also a popular mode of
transport in some countries.
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doi:10.1016/j.jvs.2006.03.037We have previously shown that the acute physiologic
responses to stationary cycling and treadmill walking are
similar in patients with intermittent claudication.9 Al-
though a recent study demonstrated some degree of benefit
of cycling in the treatment of intermittent claudication,6
the relative effectiveness of cycle training compared with
the more conventional treadmill training is not known.
Establishing this is important to the on-going process of
improving the prescription of exercise for intermittent clau-
dication. Therefore, the aim of this preliminary study was to
compare the short-term effects of cycle training with tread-
mill training on exercise tolerance and physiologic re-
sponses to exercise in claudicant patients. Performance and
physiologic responses to both treadmill and cycle exercise
were assessed so that the cross-transfer of effects between
exercise modes could also be determined.
METHODS
Subject identification. A total of 694 patients with a
reduced ankle-brachial index (ABI) (0.9) in at least one
limb and a documented history (1 year) of intermittent
claudication were consecutively identified over a 17-month
recruitment period. Patients were excluded because they
lived 50 km from the research venue (n  340), did not
respond to the invitation to participate (n  88), or were
unable to participate for personal reasons (n  87). Other
patients were deemed ineligible because of reduced cardiac
function or unstable angina (n  60), rest pain (n  18),
had recently undergone surgery or had a cardiovascular
event (n  20), or had other medical conditions for which
exercise testing and training were contraindicated (n9).
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patients were identified for further screening and gave their
written informed consent to the experimental procedures,
which were approved by the ethics committees of the Royal
Brisbane and Women’s Hospital, University of Queens-
land, and Queensland University of Technology. The pre-
study screening test was a maximal graded treadmill test
with electrocardiographic (ECG) monitoring and ABI
measurements before and after exercise. Five patients were
subsequently excluded because they were not primarily
limited by claudication, and a further 19 patients were
excluded because of ischemic ECG changes or uncon-
trolled hypertension. The remaining 43 patients were lim-
ited by claudication, displayed a positive ABI response
during walking (20 mm Hg fall), and were therefore eligi-
ble for randomization.
Subjects were stratified by gender and the presence or
absence of diabetes to ensure an equal distribution of these
characteristics among the experimental groups; that is,
before randomization, subjects were allocated to the fol-
lowing groups: male diabetic, male nondiabetic, female
diabetic, or female nondiabetic. A closed envelope system
was used to randomize subjects from these stratified groups
to a control group, a cycle-training group, or a treadmill-
training group. Body weight and heart rate were measured
during quiet rest prior to baseline treadmill testing and
across the training period. One subject in the treadmill-





Age (years) 63 (9)
Weight (kg) 74.9 (14.6)
Heart rate (beats/min) 70 (11)
SBP (mm Hg) 139 (16)
DBP (mm Hg) 69 (8)
ABI
High ABI leg 0.96 (0.26)

















SBP, Systolic blood pressure; DBP, diastolic blood pressure; ABI, ankle-bra
*A significant difference between the control and cycle groups.training group withdrew after 1 week of training because ofwork-related commitments, and those baseline data have
been omitted. Baseline characteristics of the remaining 42
patients with claudication are summarized in Table I.
Sample size and statistical power. Maximal walking
performance was the variable about which estimates of the
current sample sizes (13 per group) and statistical power
(0.8) were made. In designing this study, we were most
concerned with detecting changes in walking performance
in response to treadmill training (compared with control)
and cycle training (compared with control). Coefficients of
variation for walking performance (CV 13% to 17%) and
the mean pretraining values were used to determine the SD
for repeatedmeasurements on each variable. Theminimum
“meaningful change” or difference in the variable is equal
to two SDs, a very conservative value that served as the
difference score used to compute the corresponding effect
sizes. All SDs of difference scores were imputed from
averaged SDs of the pre- and post-training scores found in
another study10 that used similar measurement techniques
to those adopted in the present study.
Control group. Subjects in the control group were
managed with standard cardiovascular risk factor modifica-
tion, including the appropriate antiplatelet therapy and
pharmacotherapy for hypertension, diabetes mellitus, and
hypercholesterolemia, as well as advice concerning the need
to stop smoking and to exercise.
Training groups. Subjects in the treadmill-training
ant patients and the three experimental groups




62 (6) 65 (10) 61 (10)
76.5 (17.2) 72.2 (12.7) 76.5 (14.6)
68 (13) 72 (11) 69 (10)
142 (16) 141 (19) 134 (13)
69 (8) 68 (8) 72 (7)
0.97 (0.25) 0.84 (0.27) 1.08 (0.20)*














ndex; MI, myocardial infarctionudicand cycle-training groups were also managed with standard
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they performed three supervised training sessions per week
for a period of 6 weeks. Before and after each exercise
session, patients completed a series of lower-limb stretching
exercises. During each training session, subjects completed
ten, 2-minute bouts of exercise, with each bout separated
by 2 minutes of rest. Walking was performed on motorized
treadmills (Cybex Trotter 700T, Medway, Mass), and cy-
cling was performed on cycle ergometers (Monark 818
Ergomedic, Vansbro, Sweden).
The training intensity corresponded to a workload that
elicited an oxygen uptake (VO2) equal to 80% of the peak
value measured during the baseline incremental walking or
cycling tests (next section). This workload was maintained
during the first 3 weeks of the supervised program, and
then during the last 3 weeks of training, the intensity was
increased to the maximum workload achieved during the
baseline test. Heart rate (Polar Electro-Oy Fitwatch, Kem-
pele, Finland) and patient-reported claudication pain sever-
ity (0, no pain; 1, mild pain; 2, moderate pain; 3, maximal
pain) were recorded during each exercise bout.
Exercise testing. Before training, all subjects per-
formed an initial screening treadmill test to maximum
claudication and then had a separate session aimed at
familiarizing them with all the testing apparatus and exer-
cise protocols. Subjects then completed at least two maxi-
mal graded treadmill-walking tests and two maximal
graded cycle tests over a 2-week period on four separate
days. A third test was conducted if there was 25% differ-
ence inmaximumwalking or cycling times between the two
tests.11 Performance on the last tests was taken to represent
a pretraining score.
The maximal graded walking test was performed on a
motorized treadmill (TrackMaster TMX425CP, Newton,
Kan) at a constant speed of 2.7 km/h. The treadmill
gradient was set at 0% for the first 5 minutes of the test, and
then it was increased by 2% every 3minutes until the patient
failed to sustain the task. Pain-free walking time (PFWT)
and the total time spent walking (MWT) were recorded.
This protocol is similar to that used previously by our
group,9,12-15 and it is highly reproducible (average CV 
6%) when conducted after the familiarization routine.13
The maximal graded cycle test was performed on an
electrically braked cycle ergometer (Lode Rehcor, Gro-
ningen, Netherlands) at a cadence of 60 rpm. For the first 5
minutes of the test, the power output was set at 30 W, and
thereafter, it was increased 10 W each 3 minutes until the
subject failed to sustain the required cadence. Pain-free
cycling time (PFCT) and the total time spent cycling
(MCT)were recorded. During the treadmill and cycle tests,
the site(s) and severity of claudication pain were assessed
every 60 seconds and at the end of exercise using the pain
scale.
Physiologic measurements. Heart rate and pulmo-
nary gas exchange data were collected for 2 minutes before
exercise, while the subject was seated on the cycle ergome-
ter or standing on the treadmill, as well as throughout
exercise. Heart rate was measured with a portable heart ratemonitor (Polar Electro-Oy S610i, Kemple, Finland) and
averaged over 5-second intervals. Minute ventilation (VE),
rates of oxygen consumption (VO2) and carbon dioxide
production (VCO2), and the respiratory exchange ratio
(RER  VCO2/VO2) were measured breath-by-breath
and averaged over 5-second intervals (MedGraphics
CPX/D, St. Paul, Minn). Submaximal gas exchange and
heart rate values were calculated by averaging all 5-second
samples recorded between the period of 3 minutes, 50
seconds and 4 minutes, 45 seconds of the first 5-minute
exercise stage. To identify peak values, heart rate and gas
exchange variables were averaged over 15-second intervals,
and the highest values recorded during the last 3 minutes of
the exercise test were taken as the peak values.
The ABI was measured in both legs in triplicate at rest
after 20 minutes of lying quietly. The ABI was calculated
using the systolic pressures of the highest brachial artery
and the higher of the dorsalis pedis or posterior tibial
arteries, all of which were measured within 60 seconds of
each other. An average resting ABI value for each leg was
obtained by averaging the closest two of the triplicate
measures. Immediately after each exercise test, subjects
returned to a supine position and single measures of the
ABI of both legs were repeated at 2, 4, 6, 8, and 10minutes
after exercise. The same ankle and brachial arteries used to
calculate the resting ABI were measured during the postex-
ercise period. Ankle pressures were measured with an inflat-
able cuff and Doppler ultrasound 8-MHz probe (Hunt-
leigh Muti-Doplex, Cardiff, UK), and brachial pressures
were measured with a Dinamap automated pressure mon-
itor (Critikon, Tampa, Fla).
Data analysis. Only values of variables measured dur-
ing the last of the baseline tests and the post-training test
were included in the analyses. Difference or “change”
scores were calculated as the difference between the last of
the baseline test and post-training test scores. All variables
were tested for normality using the Kolmogorov-Smirnov
test, and a log transformation was applied to stabilize the
variance in cases where variables were not normally distrib-
uted. A three-way repeated measures analysis of variance
(ANOVA) was used to detect main effects (group, time,
limb) and interactions for the resting and postexercise
(minimum value) ABI data. A two-way repeated measures
ANOVA was used to detect main effects (group, time) and
interactions (group  time) for all other variables. The
“time” factor represents the 6-week period of training.
Tukey’s honestly significant difference test was used to
locate differences when an ANOVA result was significant.
Relationships between variables were established using
Pearson’s correlation coefficient. All data are expressed as
means  SDs, unless otherwise stated. Statistical signifi-
cance was set at P  .05.
RESULTS
Baseline characteristics of the 42 claudicant patients are
summarized in Table I. Patients were well matched for age,
gender, and cardiovascular risk factors. Smoking behavior
and exercise behavior beyond the supervised training were
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Health Survey of Australia, and these behaviors remained
unchanged in all subjects over the training period. The lack
of change in exercise behavior was also confirmed by the
results of physical activity surveys that were conducted
before and after training. There were no significant main
effects (group or time) or interaction for resting and pos-
texercise (treadmill and cycle) ABI responses, body weight,
and resting heart rate, suggesting these responses were
similar before and after training.
Training sessions. Subjects in the treadmill group
completed a similar number of training sessions (16.6 
1.0) as those in the cycle group (17.0 2.3), and the total
dose of training was not different (P  .37) between the
treadmill (22.04  7.64 metabolic equivalent [MET]
hours) and cycle (22.64  7.46 MET hours) groups. The
heart rate at the end of each exercise bout, averaged over all
training sessions, was not significantly different (P  .14;
Student’s t test) between the cycle (114  24 beats/min)
and treadmill (101 19 beats/min) groups. Mean claudi-
cation pain severity during cycle training was 1.2  0.7 in
the high ABI leg and 1.6  0.5 in the low ABI leg. These
values were significantly higher (P  .05) than the corre-
sponding values observed in the treadmill-training group
(0.5  0.5 and 1.0  0.7, respectively).
Treadmill test. Before training, neither MWT nor
PFWT were different among the groups. As shown in Fig 1,
MWT was significantly increased by training in the tread-
mill group (mean difference, 240 seconds; 95% confidence
interval [CI], 119 to 361 seconds), whereas no significant
change was noted in the cycle (mean difference, 48 sec-
onds; 95% CI, –22 to 117 seconds) or control group (mean
difference, –10 seconds; 95% CI, –90 to 71 seconds). This
change in MWT in the treadmill group was significantly
greater than the corresponding change scores in the cycle
Fig 1. Maximum walking times before and after training for
patients in the treadmill, cycle, and control groups. Individual
walking times (—) and mean values (●) are shown. *Indicates a
significant change in maximum walking time from pretraining to
post-training in the treadmill group.and control groups. This outcome was not affected by theexclusion of two subjects who reported only mild or mod-
erate claudication during the baseline treadmill test. As
shown in Fig 2, the PFWT after training was significantly
longer (P  .05) for the treadmill group (412  251
seconds to 607  369 seconds) compared with the cycle
group (271  289 seconds to 263  293 seconds) and
control group (391 411 seconds to 446 442 seconds).
Submaximal and peak responses for heart rate and pulmo-
nary gas exchange measurements during the treadmill test
are listed in Tables II and III. In the treadmill group, the
change in MWT was significantly correlated (P .05) with
the training-induced changes in submaximal heart rate (r
–0.55; 95% CI, –0.73 to –0.30), peak VO2 (mL/min; r
0.77; 95% CI, 0.61 to 0.87) and peak heart rate (r 0.54;
95% CI, 0.28 to 0.72).
Cycle test. Before training, MCT was not significantly
different among the groups. As shown in Fig 3, MCT was
significantly increased by training in the cycle group (mean
difference, 93 seconds; 95% CI, 45 to 132 seconds) but was
not significantly increased in the treadmill (mean differ-
ence, 45 seconds; 95% CI, –60 to 149 seconds) or control
group (mean difference, 51 seconds; 95% CI, –128 to 230
seconds) (Fig 3). This change in MCT in the cycle group
was significantly greater than the corresponding change
score in the control group but was not significantly greater
than the change score in the treadmill group. PFCT was
also not different among the groups before training andwas
not affected by training (Fig 4). Submaximal and peak
responses for heart rate and pulmonary gas exchange mea-
surements during the cycle test are summarized in Tables II
and III. In the cycle group, the change in MCT was not
correlated with any other measured variable.
Cycle vs walking tests. For the entire cohort, pain-
free times on the baseline cycle and treadmill tests were not
Fig 2. Pain-free walking times before and after training for pa-
tients in the treadmill, cycle, and control groups. Individual walk-
ing times (—) and mean values (●) are shown. †A significant main
effect where the treadmill group was greater than the cycle group.
‡A significant main effect where post-training values were greater
than pretraining values.significantly different from each other, but MWT was sig-
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Treadmill test Cycle test
Pre (SD) Post (SD) Pre (SD) Post (SD)
HR (beats/min) †
Treadmill 89 (14) 88 (13) 93 (15) 95 (14)
Cycle 104 (21) 103 (18) 106 (23) 104 (27)*
Control 93 (12) 92 (11) 93 (13) 94 (17)
VO2 (mL/min)
‡
Treadmill 726 (185) 689 (234) 693 (134) 687 (163)
Cycle 741 (205) 752 (211) 692 (90) 673 (100)
Control 695 (190) 669 (157) 674 (77) 666 (72)
VO2 (mL · kg
–1 · min–1)
Treadmill 9.6 (1.6) 9.0 (1.6) 9.2 (1.3) 9.1 (1.4)
Cycle 10.1 (1.5) 10.3 (1.7) 9.5 (1.0) 9.4 (1.1)
Control 9.0 (1.2) 8.7 (1.1) 9.0 (1.4) 8.9 (1.1)
RER
Treadmill 0.96 (0.09) 0.96 (0.08) 1.07 (0.09) 1.08 (0.09)
Cycle 0.98 (0.06) 0.97 (0.07) 1.12 (0.13) 1.08 (0.11)
Control 0.95 (0.09) 0.96 (0.08) 1.05 (0.11) 1.07 (0.10)
VE (L/min)
Treadmill 23.6 (6.7) 22.2 (7.2) 24.5 (4.9) 24.3 (5.9)
Cycle 24.2 (6.3) 24.4 (5.7) 24.9 (3.0) 24.1 (3.7)
Control 22.5 (7.5) 22.0 (6.3) 22.7 (3.0) 23.5 (2.5)
HR, Heart rate; RER, respiratory exchange ratio.
Comparisons have only be made between values pertaining to a given exercise test. “Pre” refers to the last of the baseline tests, and “post” refers to the test
performed at the end of 6 weeks of training.
*A significant effect of training in the cycle group.
†A main effect where the cycle group is greater than the treadmill group.
‡A main effect where the cycle group is greater than the control group.Table III. Peak physiologic responses during the maximal exercise tests in the three experimental groups
Treadmill test Cycle test
Pre (SD) Post (SD) Pre (SD) Post (SD)
HR (beats/min)
Treadmill 115 (23) 118 (20) 123 (25) 125 (24)
Cycle 122 (19) 123 (19) 131 (25) 131 (26)
Control 127 (27) 127 (24) 128 (26) 127 (24)
VO2 (mL/min)
† †
Treadmill 1140 (307) 1202 (308) 1126 (291) 1166 (337)
Cycle 1052 (384) 1154 (406) 1041 (370) 1115 (395)
Control 1263 (418) 1251 (435) 1236 (446) 1221 (423)
VO2 (mL · kg
–1 · min–1) †
Treadmill 15.2 (4.0) 15.8 (2.3) 15.0 (3.7) 15.6 (4.0)
Cycle 14.4 (4.4) 15.8 (4.8) 14.4 (4.6) 15.4 (4.9)*
Control 16.6 (4.9) 16.4 (4.9) 16.2 (4.9) 16.1 (4.7)
RER †
Treadmill 1.15 (0.09) 1.19 (0.09) 1.29 (0.10) 1.29 (0.11)
Cycle 1.17 (0.10) 1.18 (0.10) 1.34 (0.11) 1.30 (0.11)
Control 1.22 (0.07) 1.20 (0.11) 1.32 (0.09) 1.28 (0.11)
VE (L/min)
†
Treadmill 41.7 (12.2) 44.8 (9.8) 49.2 (11.9) 49.2 (12.4)
Cycle 40.5 (12.9) 44.1 (12.3) 46.7 (10.7) 48.9 (10.6)
Control 49.1 (18.6) 49.1 (21.6) 56.0 (25.8) 53.0 (22.5)
HR, Heart rate; RER, respiratory exchange ratio.
Comparisons have only be made between values pertaining to a given exercise test. “Pre” refers to the last of the baseline tests, and “post” refers to the test
performed at the end of six weeks of training.
SD is shown in parenthesis.
*A significant effect of training in the cycle group for the treadmill and cycle test.
†A main effect where post-training values are significantly different from pretraining values for the test (treadmill and/or cycle) indicated.
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95% CI, 51.7 to 307.5 seconds; paired t test). Submaximal
and peak physiologic responses were not different between
these cycle and treadmill tests. Many of these responses to
both baseline exercise tests (ie, cycle vs treadmill) were
significantly correlated (P  .05), particularly maximal
exercise time (r  0.75), peak VO2 (r  0.91) and ABI 2
minutes after exercise in the low ABI (r  0.83) and high
ABI leg (r  0.86).
The number of symptoms that limited performance
and were cited as the reasons for stopping exercise varied
between one and three, and there was some variation in the
anatomic location of these symptoms. For the baseline
treadmill test, these symptoms included pain in the calves
(n  33), gluteals (n  8), hamstrings (n  7), and
quadriceps (n  4), as well as dyspnea (n  5) and general
fatigue (n  5). Six subjects did not cite claudication as a
Fig 3. Maximum cycling times before and after training for pa-
tients in the treadmill, cycle, and control groups. Shown are
individual walking times (—) and mean values (●).*A significant
effect of training on maximum cycling time in the cycle group.
Fig 4. Pain-free cycling time before and after training for patients
in the treadmill, cycle and control groups. Individual walking times
(—) and mean values (●) are shown.main reason for stopping treadmill exercise, although fourreported maximal claudication pain during the test. Two of
these subjects reported only mild or moderate pain during
baseline treadmill testing despite reporting maximal clau-
dication during the screening treadmill test before baseline
testing.
For the baseline cycle test, the limiting symptoms in-
cluded pain in the quadriceps (n  27), calves (n  16),
hamstrings (n 2), and gluteals (n 1), as well as dyspnea
(n  8) and general fatigue (n  4). Five subjects did not
cite claudication as a main reason for stopping cycle exer-
cise, and two of them did not experience claudication
during the test. Half of the subjects (n 21) shared at least
one similar limiting symptom between the baseline cycle
and treadmill tests.
Treadmill training had a significantly larger effect (P 
.05) onMWT (240 178 seconds) than cycle training had
on MCT (93 98 seconds). Training pain level in the low
ABI limb tended to be correlated (P  .06) with the effect
of treadmill training on MWT (r –0.54; n 13; 95% CI
 –0.84 to 0.02); but it was not correlated (r –0.2) with
the effect of cycle training on MCT.
In the 28 trained subjects, training pain level in the low
ABI limb was inversely correlated with the specific effect of
training onmaximal exercise time (r –.53; 95%CI, –0.75
to –0.20). With respect to the effects of training on cycle
and treadmill performance in the 28 trained subjects, no
significant correlations were found between the changes in
maximal cycling and treadmill times (r  0.01 to 0.27).
However, a significant correlation was found between the
training-induced changes in maximal cycle and treadmill
times in those subjects who reported at least one limiting
symptom that was in the same anatomic location during
treadmill and cycle exercise before training (Fig 5, A), but
no correlation was found in those who reported limiting
symptoms in a different anatomic location during treadmill
and cycle exercise (Fig 5, B). Age was also significantly
correlated with the effect of cycle training on MWT (r 
0.62; P  .05).
Responders vs nonresponders. For each subject who
trained, a positive response to training occurred if the effect
of training on maximal exercise time exceeded the differ-
ence between the last two baseline tests (ie, MWT for
treadmill group, MCT for cycle group). According to this
criterion, 11of the 13 subjects in the treadmill group and 8
of the 15 subjects in the cycle group responded positively to
training. A similar analysis in the control group (ie, scores
before and after vs baseline variation) revealed three re-
sponders for MWT and one responder for MCT. Compar-
isons of baseline characteristics, baseline performances, and
training variables between responders (n 19) and nonre-
sponders (n  9) were performed. Only training pain
severity in the low ABI leg was significantly different (P 
.05) between the responders (1.1  0.7) and nonre-
sponders (1.8  0.6).
DISCUSSION
Optimizing the exercise program for patients with clau-
dication depends on knowing the effects of the various
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mode. A meta-analysis of training studies performed up
until the mid-1990s suggested that an optimal exercise
program aimed at improving walking performance should
use walking as the mode of exercise.4 This suggestion,
however, was based on studies that had not systematically
compared the effects of alternative modes of exercise with
walking. To our knowledge, the present study is the first to
contrast cycle with treadmill training, controlling for all
other major dimensions of training, and it is one of only
eight randomized controlled exercise trials to have studied
40 patients.
Six weeks of treadmill training improved graded walk-
ing performance by an average of 25%. In contrast, cycle
training did not improve graded walking performance even
though it significantly improved graded cycle performance.
Fig 5. The relationship between the training-induced changes in
maximal treadmill and cycle times in claudicant patients who
reported (A) at least one exercise-limiting symptom that was in the
same anatomic location or (B) exercise-limiting symptoms that
were in a different anatomic location during baseline treadmill and
cycle tests.In addition, although treadmill training improved walkingperformance, it failed to increase cycle performance. These
preliminary findings suggest that the training effects in-
duced by cycling or walking are specific to the mode of
exercise used during training and that there is no cross-
training benefit.
In the treatment of walking intolerance, the efficacy of
alternative modes of exercise requires a significant transfer
of physiologic adaptation to walking. The findings of our
study suggest that this is generally not the case for cycling,
despite the strong associations between cycling andwalking
performance before and after training (r  0.72 to 0.75).
Claudication in the calf and quadriceps muscles was the
most frequently cited symptom during treadmill walking
and cycling, respectively. It is perhaps this difference in the
location of claudication between the two modes of exercise
that has lead some to suggest that cycling would not be
beneficial to PAD patients, who most frequently have clau-
dication in the calf.16 However, the number of limiting
symptoms during both modes of exercise varied between
one and three (see Results), and 50% of the subjects re-
ported a similar limiting symptom during cycling and tread-
mill exercise. Among the two groups of claudicant patients
that trained (n  28) and who had a similar limiting
symptom between cycling and walking (n  12), evidence
of a cross-training effect was observed in the form of a
significant association between the training effects on max-
imum walking and cycle times (Fig 5). Seven were in the
cycle group, and five improved their maximum walking
time by a mean increase of 35% beyond the baseline varia-
tion in this measurement and by more than the mean
response seen in the treadmill group.
These data suggest that the similarity of symptoms
between cycling and walking might help determine the
effect of cycle training on walking performance. However,
age was also positively related to the effect of cycle training
on maximum walking time, and so we cannot exclude the
possibility that age affects the responsiveness to training.
Further research is clearly required to explore if the similar-
ity of symptoms between exercise modes or age, or both,
influences the performance benefit obtained from cycle
training.
A novel finding of the present study was the larger
effect of treadmill training on maximal walking time com-
pared with the effect of cycle training on maximal cycle
time. This larger, specific effect of treadmill training (mean
increase, 24% vs 10%) could not be attributed to differences
in any of the measured baseline characteristics (Table I) or
other dimensions of training, which were similar between
the training programs. Excluding nonresponders from
analyses had little effect on this difference in training effect.
In contrast, levels of training pain in both limbs were
significantly higher in the cycle than the treadmill group,
and training pain level in the low ABI limb was inversely
related to the specific effect of training on maximal exercise
time. These data raise the possibility that the smaller train-
ing response to cycling might be related to the significantly
higher pain levels reported by the cycle group. Moreover,
they suggest that in response to both forms of training, a
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those subjects who experienced lower and milder levels of
claudication pain during the training sessions. This conflicts
with the suggestion that an optimal training program
for patients with claudication consists of exercise to near-
maximal pain.4 Further study of this link between training
pain and physiologic adaptation to training is required
because the present data suggest that high levels of claudi-
cation pain might not be optimal.
Although a number of studies have examined the train-
ing effects of cycling combined with other forms of exer-
cise, only one other study has tested the effects of cycle
training alone.6 That study reported that cycle training
significantly improved walking performance. In trying to
explain how this effect differs from that observed in the
present study, several factors need to be considered.
First, it is unlikely that the training stimulus was rela-
tively lower in the present study. The training program was
modeled on that used by Walker et al,6 and training was
performed more frequently (3 vs 2 sessions per week).
Moreover, the increase in cycle performance and peak VO2
demonstrates that it provided a significant physiologic stim-
ulus.
Second, our familiarization routine of several baseline
testing sessions 9,12-15,17 might help reduce the confound-
ing influence that task learning and lowered anxiety makes
to the so-called training responses, and it is not clear what
familiarization was provided in the other study.6
Third, in contrast to the treadmill testing of one patient
at a time, these investigators used an indoor shuttle walk
test where more than one patient was tested simulta-
neously. All but one of the 24 subjects in their cycle training
group appeared to improve their maximum walking dis-
tance, and this relatively homogenous response raises the
question of the psychologic influence of training and per-
forming tests together on an individual’s walking perfor-
mance after training.
Fourth, one subject in their study appeared to improve
performance by more than 1000%, and while this wouldn’t
affect the significance of the group effect, it would greatly
inflate the average size of the effect reported (ie, 50%).
Fifth, the study did not report the symptoms that
limited walking performance, and the heart rates measured
during exercise (about 160 beats/min) far exceed the
maximal heart rates of 110 to 120 beats/min observed in
the present and other studies.2,9,10 This raises the possibil-
ity that cardiac dysfunction and symptoms other than clau-
dication contributed more to exercise limitations than was
the case in the present study.
Over several decades there has been considerable inter-
est in the physiologic mechanisms that underpin the train-
ing effect on exercise tolerance in PAD3,18,19; yet despite
this and the large number of factors suggested to be in-
volved in the training response, this problem is not well
understood.20 An improvement in performance might be
underpinned by an improvement in exercise time in the
absence or presence of pain as well as in the physiologic
responses associated with these two phases of exercise.Pain-free time during the treadmill test was improved sig-
nificantly by treadmill training in the present study, and this
improvement explained 80% of the increase in maximal
time on this test. In contrast, cycle training had no signifi-
cant effect on pain-free time during the cycle test and thus
made very little contribution to the increase in maximal
cycle time. Thus, the specific effect of training differs mark-
edly between cycling and walking: the improvement in
maximal performance induced by both modes of training is
linkedmainly to a delay in the onset of pain for walking, and
an extension of the time spent exercising with pain for
cycling. This novel finding raises the possibility that the
physiologic adaptations to training also differ between cy-
cling and walking.
In the present study, we used a graded exercise protocol
with a 5-minute initial stage that enabled physiologic re-
sponses to reach a steady-state in most patients.13,14,17 For
treadmill exercise, there was a tendency towards a signifi-
cant interactive effect on submaximal VO2 (group-by-test,
P  .07), where VO2 was lowered by training in the
treadmill, but not cycle, group. These data are consistent
with the above-mentioned effects of treadmill training on
pain-free time during treadmill walking, demonstrating a
link between increased time without pain and a lowered
oxygen cost of exercise during this mode of exercise. These
findings are similar to those observed after the same6,10 or
longer periods of training,2,5,10 where VO2 and blood
lactate concentration during treadmill exercise were re-
duced by treadmill training.
However, neither of those studies nor the present study
shed light on how the oxygen cost of exercise was lowered;
but it might relate to improved walking technique, recruit-
ment of a smaller number of motor units or recruitment of
less economical type II muscle fibers, or both.12 In contrast
to the submaximal VO2 response, peak VO2 was not sig-
nificantly increased during treadmill exercise by treadmill
training, a finding consistent with the only other training
study of the same duration to have made these measure-
ments.10 However, peak VO2 during cycle exercise was
significantly increased by cycle training. This suggests that
the improvement in cycle performance in the cycle group,
which was underpinned by an increase in the time spent
exercising with pain, was linked to increases in the peak
rates of oxygen delivery to, and/or oxygen consumption
by, working muscles.
Some limitations of this study should be considered.
Although the sample size of this study compares favorably
with other randomized controlled exercise training studies,
small effects might go undetected, and a type II error might
have occurred. This probably applies most to the effect of
cycle training given that it increased walking performance
by an average of about 5% more than the effect observed in
the control group. Whether or not such an effect on a
graded test translates into a clinically relevant effect in the
life of a patient is difficult to determine at present. The
study was powered to detect larger differences (about 10%)
in graded treadmill performance than were observed for the
control group, but given the natural variation in exercise
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ments less than this are of questionable significance from a
physiologic and clinical perspective. Given the number of
comparisons made in this study and that we did not adjust
the level of significance accordingly, we acknowledge that
we might have committed a type I error for any of the
significant effects or correlations we observed.
The duration of the study was restricted to 6 weeks, and
given that longer training programs will elicit larger in-
creases in performance, it is possible that the present study
underestimates the training benefit that might be obtained
with cycling. However, the duration of the training pro-
gram studied here is consistent with the trend in some
countries, such as Australia and the United States, of pro-
viding relatively short periods of supervised intervention
that are then followed by longer periods of home-based
intervention and allied health support.
CONCLUSION
This is the first study, to our knowledge, to compare
the effect on walking performance induced by cycle or
treadmill training in PAD patients with claudication. On
average, cycle training over a 6-week period did not signif-
icantly improve walking performance. Response to cycle
training varied considerably, however, and five of the 15
claudicant patients in the cycle group improved their walk-
ing performance. This responsiveness to training might be
influenced by age, the severity of muscle pain during train-
ing, the similarity of symptoms between cycling and walk-
ing, or a combination of these. These preliminary findings
deserve further study before cycle training is abandoned as
a potential exercise prescription for selected patients with
claudication.
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